COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

May 19, 2022 00:22:48
Episode Cover

Refractory OHCA - Does ECPR and Early Angiography Improve Outcome?

In a recent podcast we reviewed the ARREST Trial, which demonstrated significant improvement in survival among OHCA patients at a single center randomized to...

Listen

Episode 0

March 19, 2019 00:18:13
Episode Cover

BMV for ETI in the Critically Ill?

More than 1.5 million patients undergo endotracheal intubation each year in the U.S.  Endotracheal intubation can be complicated by hypoxemia, which is a known...

Listen

Episode 0

January 26, 2021 00:22:57
Episode Cover

The Critically Ill Patient with Aortic Stenosis

Patients with severe aortic stenosis who present with acute decompensated heart failure are among the most challenging patients to resuscitate.  In this podcast, we...

Listen